UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies
AstraZeneca and GSK, the U.K.’s second and ninth most valuable companies, both saw first-quarter profits beat expectations early Wednesday. Source link
AstraZeneca and GSK, the U.K.’s second and ninth most valuable companies, both saw first-quarter profits beat expectations early Wednesday. Source link
A new frontier in biotechnology is beginning to blur the line between science fiction and reality. A startup backed by wealthy investors, including R3 Bio, is working on growing so-called “bodyoids”, human-like biological systems developed from stem cells but deliberately designed without brains. These structures are not conscious or sentient, yet they can potentially sustain…